Polymyalgia rheumatica (PMR) is diagnosed through a combination of clinical symptoms, blood tests showing inflammation, and sometimes ultrasound imaging. There is no single definitive test for PMR, so doctors piece together several findings, including your age, where you feel pain and stiffness, how your blood markers look, and how quickly you respond to a low dose of corticosteroids.
Who Gets PMR
PMR almost exclusively affects people over 50, and the current classification criteria require an age of at least 50 to even consider the diagnosis. It is two to three times more common in women than men. If you’re under 50 and experiencing widespread muscle pain and stiffness, your doctor will likely explore other conditions first.
The Symptoms Doctors Look For
The hallmark of PMR is aching and stiffness in both shoulders. This bilateral shoulder pain is a required feature under the current international classification system. Many people also have pain or limited range of motion in the hips, and the stiffness is typically worst in the morning.
Morning stiffness lasting longer than 45 minutes is a key diagnostic marker. Not just a few minutes of creakiness when you get out of bed, but a prolonged period where your shoulders, upper arms, hips, or thighs feel locked up and painful. This stiffness often makes everyday tasks like getting dressed, reaching overhead, or climbing stairs genuinely difficult. The pain tends to come on over days to weeks, sometimes seemingly overnight, which distinguishes it from conditions that develop more gradually.
Blood Tests and Inflammation Markers
Blood work plays a central role. Doctors check two markers of inflammation: the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP). In PMR, both are typically elevated. An ESR of 40 mm/h or higher and a CRP above 6 mg/l have been used as diagnostic benchmarks since the early 1980s. Abnormal levels of at least one of these markers are required under the current criteria.
These tests aren’t specific to PMR. Elevated ESR and CRP simply tell your doctor that significant inflammation is happening somewhere in your body. That’s why these results must be interpreted alongside your symptoms, age, and other findings. In rare cases, people with PMR have normal inflammatory markers at the time of diagnosis, which can delay recognition of the condition.
How the Scoring System Works
The 2012 EULAR/ACR classification criteria use a point-based system. To be evaluated, you must be at least 50, have new bilateral shoulder pain, and show abnormal ESR or CRP. From there, points are assigned:
- Morning stiffness lasting more than 45 minutes: 2 points
- Hip pain or limited hip range of motion: 1 point
Without ultrasound, a score of 4 or more points supports a PMR diagnosis. When ultrasound is used, additional points can come from specific imaging findings, and a score of 5 or more is needed. This scoring system helps standardize the diagnosis, but doctors still use clinical judgment, especially when the picture isn’t clear-cut.
The Role of Ultrasound
Ultrasound can strengthen a diagnosis by revealing inflammation in specific locations. The typical findings include fluid buildup in the shoulder joint, inflammation of the bursa beneath the deltoid muscle, swelling around the biceps tendon, and bursitis or fluid in the hip joint. Finding these changes in both shoulders, or in at least one shoulder and one hip, is considered indicative of PMR.
Not every doctor orders ultrasound for suspected PMR, and it isn’t strictly required. But when the diagnosis is uncertain, or when the point score falls just short, imaging can tip the balance. It’s also useful for distinguishing PMR from other conditions that cause shoulder and hip pain.
The Prednisone Response Test
One of the most distinctive features of PMR is how dramatically it responds to a low dose of corticosteroids. Doctors often use this response as a diagnostic tool. The standard approach involves starting 15 mg of prednisolone daily and evaluating how you feel after one week. In genuine PMR, most people experience a greater than 70% improvement in symptoms within that first week. Inflammatory markers in the blood typically return to normal within four weeks.
This rapid, near-complete response is so characteristic that if you don’t improve substantially on a low dose, your doctor will reconsider whether PMR is the correct diagnosis. Conditions that mimic PMR, like late-onset rheumatoid arthritis, generally require higher doses to see any benefit.
Ruling Out Other Conditions
Because PMR has no single definitive lab test, part of the diagnostic process involves excluding conditions that look similar. Late-onset rheumatoid arthritis is one of the most important to distinguish, since it can cause PMR-like shoulder and hip symptoms in older adults.
The key differentiator is antibody testing. Rheumatoid factor (RF) is positive in roughly 67% of late-onset rheumatoid arthritis cases but only about 7% of people with PMR. Anti-CCP antibodies, another marker for rheumatoid arthritis, offer good sensitivity and specificity for telling the two conditions apart. If these antibodies are present, your doctor will lean toward a rheumatoid arthritis diagnosis even if your symptoms feel like PMR. Late-onset rheumatoid arthritis also tends to show more aggressive joint inflammation on imaging.
Other conditions that may need to be ruled out include infections, cancers that cause systemic inflammation, thyroid disorders, and other inflammatory joint diseases. Your doctor may order additional blood work or imaging depending on your full clinical picture.
Screening for Giant Cell Arteritis
PMR and giant cell arteritis are closely linked conditions. Some people with PMR develop giant cell arteritis, which involves inflammation of large arteries, particularly those in the temples and the aorta. During a PMR diagnosis, your doctor should ask about symptoms that suggest this overlap.
The warning signs of giant cell arteritis include severe headaches (usually in the temple area), scalp tenderness, and jaw pain while chewing. The most urgent concern is vision changes: fleeting blurriness, double vision, or sudden vision loss. These visual symptoms require immediate treatment because untreated giant cell arteritis can cause permanent blindness. Some people with large artery involvement experience cramping pain in their arms or legs during activity, or have inflammation of the aorta that produces no symptoms at all and is only found incidentally on imaging.
If you’re being evaluated for PMR and have any of these symptoms, particularly headaches or visual disturbances, your doctor will pursue additional testing for giant cell arteritis, which may include a temporal artery biopsy or specialized imaging of the blood vessels.